Skip to main content
. Author manuscript; available in PMC: 2021 Jun 1.
Published in final edited form as: Gene Ther. 2020 Apr 27;27(12):545–556. doi: 10.1038/s41434-020-0150-z

Table 4. Pre and post infusion VCN of cells transduced with LV WASp in the presence or absence of transduction enhancers.

Normal donor CD34+ cells were transduced with LV WASp and transplanted into NBSGW mice (n=5 per group). The mean VCN ± SD for pre-infused cells, and blood (12 weeks), whole BM, BM hCD34+ cells, and spleen (16 weeks) post transplantation are shown. The fold decrease in VCN of indicated tissues [preinfusion VCN/mean VCN of each group] is shown below. VCN, vector copy number; LV, Lentiviral vector; PGE2, prostaglandin E2; CsH, cyclosporine H; BM, bone marrow.

VCN LV PGE2 LentiBOOST LentiBOOST+PGE2 CsH
Preinfusion 0.46 1.40 0.77 2.16 1.04
Blood 0.15 ± 0.03 0.20 ± 0.05 0.48 ± 0.09 0.42 ± 0.08 0.68 ± 0.2
BM 0.22 ± 0.07 0.22 ± 0.05 0.54 ± 0.10 0.47 ± 0.04 0.75 ± 0.11
hCD34+ 0.21 ± 0.12 0.23 ± 0.08 0.53 ± 0.15 0.44 ± 0.09 0.73 ± 0.17
Spleen 0.15 ± 0.03 0.28 ± 0.06 0.48 ± 0.08 0.50 ± 0.04 0.66 ± 0.14
Fold decrease versus preinfusion VCN
Blood 3.11 6.93 1.6 5.19 1.53
BM 2.09 6.42 1.43 4.64 1.39
hCD34+ 2.16 6.04 1.46 4.92 1.43
Spleen 3.14 5.07 1.61 4.29 1.58